Larotrectinib in TRK fusion-positive pediatric B-cell acute lymphoblastic leukemia. [electronic resource]
Producer: 20200908Description: 3499-3502 p. digitalISSN:- 2473-9537
- Animals
- Combined Modality Therapy
- Disease Models, Animal
- Hematopoietic Stem Cell Transplantation
- Humans
- Mice
- Molecular Targeted Therapy
- Oncogene Proteins, Fusion -- antagonists & inhibitors
- Precursor B-Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Protein Kinase Inhibitors -- pharmacology
- Proteins -- antagonists & inhibitors
- Pyrazoles -- pharmacology
- Pyrimidines -- pharmacology
- Recurrence
- Retreatment
- Treatment Outcome
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.